141 related articles for article (PubMed ID: 20446883)
21. [Pituitary magnetic resonance in women with a clinical suspicion of microprolactinoma].
Cano Sánchez A; Benito López P; Martínez Paredes M; Cara García M; Ribes Bautista R
Rev Clin Esp; 1999 Oct; 199(10):626-31. PubMed ID: 10589244
[TBL] [Abstract][Full Text] [Related]
22. Mass screening for hyperprolactinemia and prolactinoma in men.
Miyake A; Ikegami M; Chen CF; Arita N; Aono T; Tanizawa O; Yoshikawa T
J Endocrinol Invest; 1988 May; 11(5):383-4. PubMed ID: 3183301
[TBL] [Abstract][Full Text] [Related]
23. Antipsychotic medication and marked hyperprolactinaemia: iatros or true prolactinoma?
Koves IH; Jarman FC; Cameron FJ
Acta Paediatr; 2004 Nov; 93(11):1543-7. PubMed ID: 15513588
[TBL] [Abstract][Full Text] [Related]
24. [Amineptine in the differential diagnosis of hyperprolactinemic states].
Casazza S; Contessi D; Gaslini MC; Maggi G; De Vincentiis S; Motta T; D'Alberton A
Minerva Ginecol; 1988 Jun; 40(6):357-62. PubMed ID: 3144680
[No Abstract] [Full Text] [Related]
25. [Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode].
Barrimi M; El Ghazouani F; Zaimi O; Oneib B
Presse Med; 2018 Feb; 47(2):172-174. PubMed ID: 29395559
[No Abstract] [Full Text] [Related]
26. Cabergoline-induced psychotic exacerbation in schizophrenic patients.
Chang SC; Chen CH; Lu ML
Gen Hosp Psychiatry; 2008; 30(4):378-80. PubMed ID: 18585544
[TBL] [Abstract][Full Text] [Related]
27. Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
Svestka J; Synek O; Tomanová J; Rodáková I; Cejpková A
Neuro Endocrinol Lett; 2007 Dec; 28(6):881-8. PubMed ID: 18063941
[TBL] [Abstract][Full Text] [Related]
28. Pituitary tumour presenting with psychotic symptoms without neurological signs.
Ghosh AK; Jacob R; Rayapureddy S
Singapore Med J; 2012 Jul; 53(7):499-500. PubMed ID: 22815023
[No Abstract] [Full Text] [Related]
29. The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: a longitudinal MRI study.
Nicolo JP; Berger GE; Garner BA; Velakoulis D; Markulev C; Kerr M; McGorry PD; Proffitt TM; McConchie M; Pantelis C; Wood SJ
Schizophr Res; 2010 Jan; 116(1):49-54. PubMed ID: 19896337
[TBL] [Abstract][Full Text] [Related]
30. [MRI of the pituitary gland: indications and results in gynaecology and in obstetrics].
Bonneville JF; Bonneville F; Cattin F
Gynecol Obstet Fertil; 2005 Mar; 33(3):147-53. PubMed ID: 15848087
[TBL] [Abstract][Full Text] [Related]
31. Hyperprolactinaemia with amisulpride.
Ružić K; Grahovac T; Graovac M; Dadić-Hero E; Sepić-Grahovac D; Sabljić V
Psychiatr Danub; 2011 Mar; 23(1):92-4. PubMed ID: 21448106
[TBL] [Abstract][Full Text] [Related]
32. Hyperprolactinaemia due to hypothalamic-pituitary disease or drug-induced in patients with erectile dysfunction.
Venetikou MS; Lambou T; Gizani D
Andrologia; 2008 Aug; 40(4):240-4. PubMed ID: 18727734
[TBL] [Abstract][Full Text] [Related]
33. Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.
Holt RI
J Psychopharmacol; 2008 Mar; 22(2 Suppl):28-37. PubMed ID: 18477618
[TBL] [Abstract][Full Text] [Related]
34. [Amisulpride: a treatment option for psychotic disorders soon to be available in the Netherlands].
Vinkers CH; Sommer IE
Tijdschr Psychiatr; 2015; 57(11):830-4. PubMed ID: 26552930
[TBL] [Abstract][Full Text] [Related]
35. Weight gain in a patient with schizophrenia switched from quetiapine to amisulpride.
Chen YY; Huang MC; Wu KC
Psychiatry Clin Neurosci; 2008 Oct; 62(5):620-1. PubMed ID: 18950385
[No Abstract] [Full Text] [Related]
36. Atypical antipsychotics and pituitary neoplasms in the WHO database.
Doraiswamy PM; Schott G; Star K; Edwards R; Mueller-Oerlinghausen B
Psychopharmacol Bull; 2007; 40(1):74-6. PubMed ID: 17285098
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of overweight, hyperprolactinaemia and suspected Cushing's syndrome].
Iwen A; Lehnert H
Dtsch Med Wochenschr; 2010 Sep; 135(38):1880-1. PubMed ID: 20842611
[No Abstract] [Full Text] [Related]
38. [Domperidone and hyperprolactinemia].
Lu F; Wu H; Zhang K; Li D
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):100-2. PubMed ID: 10681812
[TBL] [Abstract][Full Text] [Related]
39. A case of venous thromboembolism probably associated with hyperprolactinemia after the addition of olanzapine to typical antipsychotics.
Toki S; Morinobu S; Yoshino A; Yamawaki S
J Clin Psychiatry; 2004 Nov; 65(11):1576-7. PubMed ID: 15554776
[No Abstract] [Full Text] [Related]
40. Gender, psychosis and psychotropic drugs: differences and similarities.
Groleger U; Novak-Grubic V
Psychiatr Danub; 2010 Jun; 22(2):338-42. PubMed ID: 20562777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
